Bone Biologics (BBLG) Research & Development (2014 - 2025)
Bone Biologics (BBLG) reported Research & Development of $257197.0 for Q4 2025, down 76.72% year-over-year from $1.1 million in Q4 2024, and up 36.95% quarter-over-quarter from $187808.0 in Q3 2025.
Bone Biologics (BBLG) Research & Development (2014 - 2025) Analysis & Trends
Bone Biologics (BBLG) has 12 years of Research & Development data on file, last reported at $257197.0 in Q4 2025.
- Research & Development for Q4 2025 came in at $257197.0, down 76.72% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.1 million (down 50.23% YoY), and the FY2025 annual result was $1.1 million, down 50.23% from the prior year.
- Research & Development grew to $257197.0 in Q4 2025 per BBLG's latest filing, from $187808.0 in the prior quarter.
- Over five years, Research & Development peaked at $2.6 million in Q1 2023 and troughed at $2016.0 in Q2 2021.
- A 5-year average of $618933.6 and a median of $350442.0 in 2024 frame the typical range for Research & Development.
- The sharpest annual moves came in 2023 and 2024: Research & Development surged 12941.2% in 2023, then slumped 90.52% in 2024.
- A 5-year view of Research & Development shows it stood at $34528.0 in 2021, then soared by 2089.2% to $755888.0 in 2022, then tumbled by 40.85% to $447077.0 in 2023, then jumped by 147.07% to $1.1 million in 2024, then sank by 76.72% to $257197.0 in 2025.
- Business Quant data shows BBLG's Research & Development at $257197.0 in Q4 2025, $187808.0 in Q3 2025, and $191608.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 1.46 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | -2.30 Mn |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -58.00 Mn |
| 10 | Bone Biologics | 1.47 Mn | 1.47 Mn | - | 257,197.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 257,197.00 |
| Sep 30, 2025 | 187,808.00 |
| Jun 30, 2025 | 191,608.00 |
| Mar 31, 2025 | 423,576.00 |
| Dec 31, 2024 | 1.10 Mn |
| Sep 30, 2024 | 429,747.00 |
| Jun 30, 2024 | 350,442.00 |
| Mar 31, 2024 | 245,625.00 |
| Dec 31, 2023 | 447,077.00 |
| Sep 30, 2023 | 1.57 Mn |
| Jun 30, 2023 | 2.30 Mn |
| Mar 31, 2023 | 2.59 Mn |
| Dec 31, 2022 | 755,888.00 |
| Sep 30, 2022 | 769,410.00 |
| Jun 30, 2022 | 17,600.00 |
| Mar 31, 2022 | 36,400.00 |
| Dec 31, 2021 | 34,528.00 |
| Jun 30, 2021 | 2,016.00 |
| Mar 31, 2021 | 45,500.00 |
| Dec 31, 2020 | 21,694.00 |